tradingkey.logo

Twist Bioscience Corp

TWST
48.290USD
-0.950-1.93%
交易中 美東報價延遲15分鐘
2.96B總市值
虧損本益比TTM

Twist Bioscience Corp

48.290
-0.950-1.93%

關於 Twist Bioscience Corp 公司

Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. It has applied its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next generation sequencing (NGS) sample preparation, and antibody libraries for drug discovery and development, all designed to enable its customers to conduct research. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The Company also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The Company's synthetic DNA tools are used in fields, such as medicine, agriculture, industrial chemicals and defense. It has minority ownership in Atlas Data Storage, Inc.

Twist Bioscience Corp簡介

公司代碼TWST
公司名稱Twist Bioscience Corp
上市日期Oct 31, 2018
CEOLeproust (Emily M)
員工數量979
證券類型Ordinary Share
年結日Oct 31
公司地址681 Gateway Blvd.
城市SOUTH SAN FRANCISCO
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編94080
電話18007190671
網址https://www.twistbioscience.com/
公司代碼TWST
上市日期Oct 31, 2018
CEOLeproust (Emily M)

Twist Bioscience Corp公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
414.69K
-5001.00%
Mr. Patrick John Finn, Ph.D.
Mr. Patrick John Finn, Ph.D.
President, Chief Operating Officer
President, Chief Operating Officer
98.66K
-2705.00%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
94.05K
+1343.00%
Ms. Paula Green
Ms. Paula Green
Senior Vice President - Human Resources
Senior Vice President - Human Resources
69.29K
-1194.00%
Mr. Dennis Cho
Mr. Dennis Cho
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
60.72K
-1099.00%
Mr. Adam Laponis
Mr. Adam Laponis
Chief Financial Officer
Chief Financial Officer
31.82K
-5738.00%
Mr. Nelson C. Chan
Mr. Nelson C. Chan
Independent Director
Independent Director
23.68K
+1436.00%
Dr. Melissa A. Starovasnik, Ph.D.
Dr. Melissa A. Starovasnik, Ph.D.
Independent Director
Independent Director
17.16K
+1344.00%
Mr. Jan Johannessen
Mr. Jan Johannessen
Independent Director
Independent Director
10.39K
+4834.00%
Mr. Robert B. (Rob) Chess
Mr. Robert B. (Rob) Chess
Lead Independent Director
Lead Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
414.69K
-5001.00%
Mr. Patrick John Finn, Ph.D.
Mr. Patrick John Finn, Ph.D.
President, Chief Operating Officer
President, Chief Operating Officer
98.66K
-2705.00%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
94.05K
+1343.00%
Ms. Paula Green
Ms. Paula Green
Senior Vice President - Human Resources
Senior Vice President - Human Resources
69.29K
-1194.00%
Mr. Dennis Cho
Mr. Dennis Cho
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
60.72K
-1099.00%
Mr. Adam Laponis
Mr. Adam Laponis
Chief Financial Officer
Chief Financial Officer
31.82K
-5738.00%

收入明細

單位: USD更新時間: 1月6日 週二
單位: USD更新時間: 1月6日 週二
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
NGS tools
208.10M
55.26%
Synthetic genes
113.60M
30.17%
Antibody discovery
23.45M
6.23%
Oligo pools
20.23M
5.37%
DNA libraries
11.18M
2.97%
地區USD
名稱
營收
佔比
Americas
225.58M
59.90%
EMEA
124.24M
32.99%
APAC
26.75M
7.10%
業務
地區
業務USD
名稱
營收
佔比
NGS tools
208.10M
55.26%
Synthetic genes
113.60M
30.17%
Antibody discovery
23.45M
6.23%
Oligo pools
20.23M
5.37%
DNA libraries
11.18M
2.97%

股東統計

更新時間: 11月16日 週日
更新時間: 11月16日 週日
持股股東
股東類型
持股股東
持股股東
佔比
ARK Investment Management LLC
12.33%
Artisan Partners Limited Partnership
9.51%
The Vanguard Group, Inc.
9.40%
BlackRock Institutional Trust Company, N.A.
7.85%
William Blair Investment Management, LLC
6.76%
其他
54.16%
持股股東
持股股東
佔比
ARK Investment Management LLC
12.33%
Artisan Partners Limited Partnership
9.51%
The Vanguard Group, Inc.
9.40%
BlackRock Institutional Trust Company, N.A.
7.85%
William Blair Investment Management, LLC
6.76%
其他
54.16%
股東類型
持股股東
佔比
Investment Advisor
66.28%
Investment Advisor/Hedge Fund
36.10%
Hedge Fund
9.90%
Research Firm
5.44%
Pension Fund
1.58%
Individual Investor
1.58%
Bank and Trust
0.83%
Family Office
0.17%
Insurance Company
0.07%

機構持股

更新時間: 1月1日 週四
更新時間: 1月1日 週四
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
585
73.72M
120.24%
-3.30M
2025Q3
566
71.88M
119.09%
+752.75K
2025Q2
575
70.44M
116.72%
-302.44K
2025Q1
585
70.23M
117.22%
-1.63M
2024Q4
578
67.47M
113.11%
-8.03M
2024Q3
588
67.80M
115.74%
-8.48M
2024Q2
579
66.59M
114.39%
-10.53M
2024Q1
565
68.18M
117.94%
-8.61M
2023Q4
559
67.81M
117.39%
-11.70M
2023Q3
560
68.09M
118.66%
-11.36M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
ARK Investment Management LLC
6.73M
10.98%
+326.37K
+5.10%
Sep 30, 2025
Artisan Partners Limited Partnership
6.41M
10.46%
+1.35M
+26.67%
Sep 30, 2025
The Vanguard Group, Inc.
5.76M
9.39%
-63.16K
-1.09%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
4.81M
7.85%
-46.27K
-0.95%
Sep 30, 2025
William Blair Investment Management, LLC
4.14M
6.76%
+235.68K
+6.03%
Sep 30, 2025
EdgePoint Investment Group Inc.
4.08M
6.66%
+1.70M
+71.10%
Sep 30, 2025
State Street Investment Management (US)
3.09M
5.04%
+588.07K
+23.51%
Sep 30, 2025
Amova Asset Management Co., Ltd.
2.12M
3.46%
-179.23K
-7.79%
Sep 30, 2025
Soleus Capital Management, L.P.
1.87M
3.05%
+1.51M
+426.59%
Sep 30, 2025
Millennium Management LLC
1.79M
2.93%
+1.08M
+151.55%
Sep 30, 2025
查看更多

持股ETF

更新時間: 12月2日 週二
更新時間: 12月2日 週二
機構名稱
佔比
ARK Genomic Revolution ETF
6.24%
iShares Genomics Immunology and Healthcare ETF
3.92%
Global X Genomics & Biotechnology ETF
2.09%
ROBO Global Healthcare Technology & Innovation ETF
2%
WisdomTree BioRevolution Fund
1.79%
ARK Innovation ETF
1.47%
Franklin Genomic Advancements ETF
1.17%
State Street SPDR S&P Biotech ETF
0.92%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.66%
Direxion Daily S&P Biotech Bull 3X Shares
0.56%
查看更多
ARK Genomic Revolution ETF
佔比6.24%
iShares Genomics Immunology and Healthcare ETF
佔比3.92%
Global X Genomics & Biotechnology ETF
佔比2.09%
ROBO Global Healthcare Technology & Innovation ETF
佔比2%
WisdomTree BioRevolution Fund
佔比1.79%
ARK Innovation ETF
佔比1.47%
Franklin Genomic Advancements ETF
佔比1.17%
State Street SPDR S&P Biotech ETF
佔比0.92%
First Trust Nasdaq Lux Digi Health Solutions ETF
佔比0.66%
Direxion Daily S&P Biotech Bull 3X Shares
佔比0.56%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
KeyAI